Eagle Pharmaceuticals, Inc. License Agreements
11 Contracts & Agreements
- License Agreement, dated as of August 6, 2021, between the Registrant and AOP Orphan Pharmaceuticals GmbH (Filed With SEC on November 9, 2021)
- License Agreement, dated as of August 19, 2021, between the Registrant and Combioxin SA (Filed With SEC on November 9, 2021)
- Fourth Amendment to the Exclusive License Agreement, dated April 12, 2019, by and between Eagle Pharmaceuticals, Inc., a Delaware corporation and Teva Pharmaceuticals... (Filed With SEC on May 7, 2019)
- LICENSE AGREEMENT (Filed With SEC on February 29, 2016)
- EXCLUSIVE LICENSE AGREEMENT between EAGLE PHARMACEUTICALS, INC. and CEPHALON, INC. dated February 13, 2015 (Filed With SEC on May 15, 2015)
- DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on December 20, 2013)
- DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on December 20, 2013)
- LICENSE AND DEVELOPMENT AGREEMENT (Filed With SEC on December 20, 2013)
- LICENSE AND SUBLICENSE AGREEMENT BETWEEN LYOTROPIC THERAPEUTICS, INC. AND EAGLE PHARMACEUTICALS, INC. (Filed With SEC on December 20, 2013)
- DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on December 20, 2013)
- DEVELOPMENT AND LICENSE AGREEMENT (Filed With SEC on December 20, 2013)
